Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?

Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Tonix Pharmaceuticals Stock (NASDAQ: TNXP) stock price, news, charts, stock research, profile.

Open	$0.74
Close	$0.89
Volume / Avg.	4.52M / 827.14K
Day Range	0.70 - 0.90
52 Wk Range	0.60 - 60.16
Market Cap	$6.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	22
Short Interest	25.22%
Days to Cover	1.09

Recent News

Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract

Tonix Pharmaceuticals secures a potential $34 million agreement with the Defense Threat Reduction Agency to develop antiviral agents for military use. The program aims to enhance medical readiness against biological threats.

Vandana Singh

Nike, Micron And 3 Stocks To Watch Heading Into Thursday

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Avi Kapoor

This Biopharma Stock Is Trading 23% Higher In Pre-Market After Wrapping Up $4M Public Offering

The public offering included 1,199,448 shares of common stock and pre-funded warrants to purchase up to 2,568,110 shares of common stock.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Tonix Pharmaceuticals Holding Corp

Sector

Health Care

Industry

Biotechnology

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tonix Pharmaceuticals (TNXP) stock?

You can purchase shares of Tonix Pharmaceuticals (NASDAQ:TNXP) through any online brokerage.

View our list of the best stock brokerages

Who are Tonix Pharmaceuticals (TNXP) competitors?

Other companies in Tonix Pharmaceuticals’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Synaptogenix (NASDAQ:SNPX), NuCana (NASDAQ:NCNA), Genprex (NASDAQ:GNPX) and Trevena (NASDAQ:TRVN).

What is the target price for Tonix Pharmaceuticals (TNXP) stock?

There is no analysis for Tonix Pharmaceuticals.

What is the forecast for Tonix Pharmaceuticals (TNXP) stock?

Tonix Pharmaceuticals has a consensus price target of $3.87.

Current stock price for Tonix Pharmaceuticals (TNXP)?

The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $0.8901 last updated July 3, 2024 at 4:57 PM EDT.

Does Tonix Pharmaceuticals (TNXP) pay a dividend?

There are no upcoming dividends for Tonix Pharmaceuticals.

When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?

Tonix Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Tonix Pharmaceuticals (TNXP) going to split?

There is no upcoming split for Tonix Pharmaceuticals.

What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?

Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tonix Pharmaceuticals

Tonix Pharmaceuticals (TNXP) Forecast